Highlights from the 19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting

The Asian Society for Neuro-Oncology is dedicated to the study and advancement of neuro-oncology in Asia. Neuro-oncology is a field of medicine that focuses on cancers of the brain, spine, and nervous system.

The ASNO brings together professionals, researchers, and clinicians who work in neuro-oncology, aiming to improve the understanding, diagnosis, and treatment of neurological cancers. It also serves as a platform for collaboration, sharing research, and educational initiatives within the Asian region.

ASNO was founded in 2001 with the goal of fostering collaboration among neuro-oncologists in Asia, where the incidence and challenges of treating CNS tumors may differ from other regions due to genetic, environmental, and healthcare-related factors. Since its establishment, ASNO has grown into a platform that connects neuro-oncology specialists across Asia, including researchers, clinicians, and healthcare professionals who are committed to advancing research, education, and clinical practice in this field.

ASNO organizes annual scientific conferences that bring together experts from across Asia and the world to share the latest research, clinical advancements, and best practices in neuro-oncology. These conferences serve as a key forum for networking, collaboration, and the exchange of ideas between professionals in the field.

19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting helded at the One Farrer Hotel, Singapore from 16 – 18 August 2024.

Here are some highlights from ASNO24:

Singapore Society of Neurooncology:

“We extend our heartfelt gratitude to all participants for making the Asian Society for Neuro-Oncology (ASNO) Annual Meeting 2024 a remarkable success. Your presence and active engagement have truly enriched the event, creating a memorable and impactful experience for everyone involved. Through the inspiring sessions and insightful discussions, we hope you’ve gained valuable knowledge that will greatly benefit your professional journey.

Thank you for being an integral part of ASNO 2024.”

Vincent Nga:

“Neurosurgeons, Adult and Paeds NeuroOncologists, Radiation Oncologist, Neuroradiologists, Neuropathologists, Orthopeadic Spine Surgeons and Nurses from the National University Hospital and National University Cancer Institute, Singapore; working hand-in-hand with our other local, regional and international institutions, contributed actively to the immense success of ASNO2024!
Thanks everyone for the great team work!”

Joel Foo:

“Learning loads from the giants of neuro-oncology at ASNO2024.
Kudos to SSNO for putting together such an amazing meeting.”

National University Cancer Institute, Singapore:

“Wrapping up ASNO2024! It was amazing to connect with experts and dive into the latest in neurooncology. Thank you to all who visited our booth and to SSNO for organising a great event. Stay updated on neuro-oncology – subscribe to our newsletter.”

Pankaj Kumar Panda:

“Kevin Chua as the congress co-chair announcing and inviting everyone for the next Asian Society of Neuro Oncology ASNO2024 in Singapore. See you all in Singapore!”

Sammy Shaya:

“The Brain Cancer Centre this week was represented at ASNO24 where I shared our trial concept for Rapid Intraoperative Sequencing for Treatment Stratification in Glioblastoma with Oxford Nanopore.

Difficult to treat cancers need novel trial designs.”

For the latest updates on ASNO2024, visit oncodaily.com